BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Genexine Merges with EPD Bio to Advance Targeted Protein Degradation Technology

Merger with EPD Bio, a biotech developing a target protein degrader (TPD) platform technology Jaehyun Choi, Ph.D. founder and CEO of EPD Bio, join...

July 08, 2024 | News

XPOVIO® Secures NMPA Approval for Treatment of R/R DLBCL in China, Expanding Its Indications

- Following its initial approval for the treatment of relapsed/refractory multiple myeloma (R/R MM), XPOVIO® has now received approval as a monoth...

July 08, 2024 | News

Aptamer Group and AstraZeneca Collaborate to Advance Targeted siRNA Delivery for Fibrotic Liver Cells

Aptamer Group , the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce a new agreem...

July 05, 2024 | News

South Korea's Genexine Merges with EPD Biotherapeutics to Enhance PROTAC Technology and Drug Pipeline

Genexine a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the tre...

July 05, 2024 | News

Eisai Reclaims Full Rights to Farletuzumab Ecteribulin After Ending Collaboration with Bristol Myers Squibb

Eisai Co., Ltd. announced that it has agreed to end its global strategic collaboration with Bristol Myers Squibb for the co-development and c...

July 04, 2024 | News

Menarini Silicon Biosystems' Fetal Cell-Based NIPT Shows High Accuracy in Genomic Profiling at 2024 FMF World Congress

Data presented at the 2024 FMF (Fetal Medicine Foundation) World Congress in Lisbon, Portugal shows the potential for an automated syst...

July 02, 2024 | News

Thermo Fisher Scientific Introduces Biobased Films for Bioprocessing Containers to Enhance Sustainability in Biologics Manufacturing

Thermo Fisher Scientific Inc., the world leader in serving science, is contributing to the sustainability of biologics therapy manufacturing by leveraging ...

July 01, 2024 | News

Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability

Sirnaomics , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group h...

July 01, 2024 | News

Cytiva Introduces Supor Prime Filters to Enhance High-Concentration Biologic Drug Manufacturing

Global life sciences leader Cytiva is addressing the distinct filtration needs of customers manufacturing high-concentration biologic drugs with its Supor ...

June 28, 2024 | News

Jubilant Radiopharma Invests $50 Million to Expand PET Radiopharmaceutical Manufacturing Facilities in the U.S.

Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manuf...

June 25, 2024 | News

EU Approves HUTCHMED's FRUZAQLA® for Previously Treated Metastatic Colorectal Cancer

— Approval for previously treated metastatic colorectal cancer based on results from positive, global, Phase III FRESCO-2 Trial — — FRUZ...

June 24, 2024 | News

Merck’s SMCxPRO® Immunoassay Technology Advances Parkinson’s Disease Research Through MJFF Collaboration

SMC® immunoassay technology from Merck detects small changes in biomarker levels, indicating level of cell dysfunction New understanding of cel...

June 24, 2024 | News

Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Advanced Cancer Profiling Services to Middle East and Africa

Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, h...

June 24, 2024 | News

Sarepta Therapeutics Secures FDA Approval for Expanded Use of ELEVIDYS in Duchenne Muscular Dystrophy Patients

Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, today announced U.S. Food and Drug Administration (FDA) approv...

June 21, 2024 | News

Stay Connected